Page last updated: 2024-08-26

widdrol and Angiogenesis, Pathologic

widdrol has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jeong, HY; Jin, S; Kim, BW; Kwon, HJ; Oh, YN; Park, HJ; Yun, HJ; Yun, SG	1

Other Studies

1 other study(ies) available for widdrol and Angiogenesis, Pathologic

Article	Year
Widdrol, a sesquiterpene isolated from Juniperus chinensis, inhibits angiogenesis by targeting vascular endothelial growth factor receptor 2 signaling. Oncology reports, 2015, Volume: 34, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Benzocycloheptenes; Blotting, Western; Female; Flow Cytometry; Human Umbilical Vein Endothelial Cells; Humans; Juniperus; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Neovascularization, Physiologic; Plant Extracts; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2015

Article

Year

Widdrol, a sesquiterpene isolated from Juniperus chinensis, inhibits angiogenesis by targeting vascular endothelial growth factor receptor 2 signaling.

Oncology reports, 2015, Volume: 34, Issue:3

Topics: Angiogenesis Inhibitors; Animals; Benzocycloheptenes; Blotting, Western; Female; Flow Cytometry; Human Umbilical Vein Endothelial Cells; Humans; Juniperus; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Neovascularization, Physiologic; Plant Extracts; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2015